Evan M Sisson Selected Research

4-nitro-3-dimethylaminopropiophenone

9/2022	Survey of CDC-recognized community pharmacies providing the National Diabetes Prevention Program and impact of the COVID-19 pandemic on program delivery.
4/2021	An ounce of prevention is worth a pound of cure: considerations for pharmacists delivering the National Diabetes Prevention Program.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Evan M Sisson Research Topics

Disease

3	Type 2 Diabetes Mellitus (MODY) 09/2022 - 09/2011
3	Weight Loss (Weight Reduction) 01/2020 - 09/2011
2	Injection Site Reaction 10/2019 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 07/2017
2	Coronary Disease (Coronary Heart Disease) 01/2018 - 09/2014
2	Dyslipidemias (Dyslipidemia) 01/2018 - 01/2018
2	Pancreatitis 07/2017 - 09/2011
1	COVID-19 09/2022
1	Prediabetic State (Prediabetes) 04/2021
1	Myocardial Infarction 01/2019
1	Heart Failure 01/2018
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2018
1	Chronic Disease (Chronic Diseases) 10/2017
1	Hypertriglyceridemia 07/2017
1	Homozygous Familial Hypercholesterolemia 09/2014
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2014
1	medullary Thyroid cancer 09/2011
1	Hypoglycemia (Reactive Hypoglycemia) 09/2011

Drug/Important Bio-Agent (IBA)

3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020 - 09/2011
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2018
2	4-nitro-3-dimethylaminopropiophenoneIBA 09/2022 - 04/2021
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 10/2019
2	oxidized low density lipoproteinIBA 01/2019 - 09/2014
2	LDL CholesterolIBA 01/2019 - 09/2014
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	semaglutideIBA 01/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2019
1	PCSK9 InhibitorsIBA 01/2019
1	AntioxidantsIBA 01/2018
1	coenzyme Q10 (CoQ10)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 07/2017
1	LDL Receptors (LDL Receptor)IBA 09/2014
1	LipidsIBA 09/2014
1	mipomersenIBA 09/2014
1	BMS201038IBA 09/2014
1	Liraglutide FDA Link 09/2011
1	Insulin (Novolin)FDA Link 09/2011

Therapy/Procedure

3	Therapeutics 10/2019 - 01/2018
2	Glycemic Control 10/2019 - 01/2018
1	Ambulatory Care (Outpatient Care) 10/2017
1	Drug Therapy (Chemotherapy) 07/2017